Baba, Y.; Maeda, T.; Suzuki, A.; Takada, S.; Fujii, M.; Kato, Y.
Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 2017, 18, 262.
https://doi.org/10.3390/ijms18020262
AMA Style
Baba Y, Maeda T, Suzuki A, Takada S, Fujii M, Kato Y.
Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2017; 18(2):262.
https://doi.org/10.3390/ijms18020262
Chicago/Turabian Style
Baba, Yuh, Toyonobu Maeda, Atsuko Suzuki, Satoshi Takada, Masato Fujii, and Yasumasa Kato.
2017. "Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma" International Journal of Molecular Sciences 18, no. 2: 262.
https://doi.org/10.3390/ijms18020262
APA Style
Baba, Y., Maeda, T., Suzuki, A., Takada, S., Fujii, M., & Kato, Y.
(2017). Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences, 18(2), 262.
https://doi.org/10.3390/ijms18020262